Projected Income Statement: Zai Lab Limited

Forecast Balance Sheet: Zai Lab Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -1,409 -1,008 -791 -758 -565 -458 -381 -237
Change - 28.46% 21.53% 4.17% 25.46% 18.98% 16.81% 37.8%
Announcement Date 3/1/22 A 3/1/23 A 2/27/24 A 2/27/25 A 2/26/26 A - - -
1USD in Million
Estimates

Cash Flow Forecast: Zai Lab Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 18.3 24.58 7.212 5.657 13.42 15.99 17.51 19.1
Change - 34.38% -70.67% -21.56% 137.3% 19.11% 9.48% 9.13%
Free Cash Flow (FCF) 1 -567.5 -392.2 -205.4 -220.5 -164.2 -184.1 -147.6 -104.3
Change - 30.89% 47.63% -7.37% 25.54% -12.14% 19.85% 29.31%
Announcement Date 3/1/22 A 3/1/23 A 2/27/24 A 2/27/25 A 2/26/26 A - - -
1USD in Million
Estimates

Forecast Financial Ratios: Zai Lab Limited

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) -480.61% -184.21% -134.05% -67.74% -46.6% -68.87% -32.38% -14.37%
EBIT Margin (%) -485.1% -188.04% -137.44% -70.71% -49.86% -71.37% -34.96% -16.86%
EBT Margin (%) -487.43% -206.04% -125.46% -64.44% -38.78% -56.98% -29.27% -21.85%
Net margin (%) -488.16% -206.14% -125.46% -64.44% -38.15% -56.86% -31.1% -21.03%
FCF margin (%) -393.26% -182.4% -77.01% -55.27% -35.69% -43.54% -25.78% -14.47%
FCF / Net Income (%) 80.56% 88.48% 61.38% 85.77% 93.55% 76.58% 82.89% 68.82%

Profitability

        
ROA -48.46% -31.33% -29.66% -23.14% -14.89% -28.6% -20.74% -16.7%
ROE -55.27% -36.55% -36.34% -31.41% -22.56% -41.11% -42.4% -32.16%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 12.68% 11.43% 2.7% 1.42% 2.92% 3.78% 3.06% 2.65%
CAPEX / EBITDA (%) -2.64% -6.21% -2.02% -2.09% -6.26% -5.49% -9.44% -18.45%
CAPEX / FCF (%) -3.22% -6.27% -3.51% -2.57% -8.17% -8.68% -11.86% -18.31%

Items per share

        
Cash flow per share 1 -5.906 - - -2.172 - -1.45 -2.72 -
Change - - - - - - -87.59% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 14.45 - 8.189 7.803 6.467 4.353 3.935 3.659
Change - - - -4.72% -17.12% -32.69% -9.59% -7.01%
EPS 1 -7.58 -4.63 -3.46 -2.6 -1.6 -2.265 -2.152 -1.651
Change - 38.92% 25.27% 24.86% 38.46% -41.54% 4.97% 23.28%
Nbr of stocks (in thousands) 96,409 95,972 98,349 108,937 111,219 112,266 112,266 112,266
Announcement Date 3/1/22 A 3/1/23 A 2/27/24 A 2/27/25 A 2/26/26 A - - -
1USD
Estimates
2026 *2027 *
P/E -11.3x -11.8x
PBR 5.86x 6.48x
EV / Sales 5.68x 4.33x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.49USD
Average target price
32.18USD
Spread / Average Target
+26.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ZLAB Stock
  4. Financials Zai Lab Limited